Janusz et al., 1998 - Google Patents
New cyclooxygenase-2/5-lipoxygenase inhibitors. 1. 7-tert-butyl-2, 3-dihydro-3, 3-dimethylbenzofuran derivatives as gastrointestinal safe antiinflammatory and …Janusz et al., 1998
- Document ID
- 12381144917100396311
- Author
- Janusz J
- Young P
- Ridgeway J
- Scherz M
- Enzweiler K
- Wu L
- Gan L
- Darolia R
- Matthews R
- Hennes D
- Kellstein D
- Green S
- Tulich J
- Rosario-Jansen T
- Magrisso I
- Wehmeyer K
- Kuhlenbeck D
- Eichhold T
- Dobson R
- Sirko S
- Farmer R
- Publication year
- Publication venue
- Journal of medicinal chemistry
External Links
Snippet
A series of 5-keto-substituted 7-tert-butyl-2, 3-dihydro-3, 3-dimethylbenzofurans (DHDMBFs) were prepared and evaluated as potential nonsteroidal antiinflammatory and analgesic agents. Interest in this class of compounds arose when a DHDMBF was found to be an …
- 230000002496 gastric 0 title abstract description 21
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/12—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulfur
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulfur with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Janusz et al. | New cyclooxygenase-2/5-lipoxygenase inhibitors. 1. 7-tert-butyl-2, 3-dihydro-3, 3-dimethylbenzofuran derivatives as gastrointestinal safe antiinflammatory and analgesic agents: Discovery and variation of the 5-Keto substituent | |
| Battilocchio et al. | A class of pyrrole derivatives endowed with analgesic/anti-inflammatory activity | |
| Huang et al. | Diarylspiro [2.4] heptenes as orally active, highly selective cyclooxygenase-2 inhibitors: synthesis and structure− activity relationships | |
| Reichstein et al. | Synthesis and structure–activity relationships of lapacho analogues. 1. Suppression of human keratinocyte hyperproliferation by 2-substituted naphtho [2, 3-b] furan-4, 9-diones, activation by enzymatic one-and two-electron reduction, and intracellular generation of superoxide | |
| Velázquez et al. | Novel nonsteroidal antiinflammatory drugs possessing a nitric oxide donor diazen-1-ium-1, 2-diolate moiety: design, synthesis, biological evaluation, and nitric oxide release studies | |
| Solangi et al. | Indole acrylonitriles as potential anti-hyperglycemic agents: Synthesis, α-glucosidase inhibitory activity and molecular docking studies | |
| Hammuda et al. | Design and synthesis of novel chalcones as potent selective monoamine oxidase-B inhibitors | |
| Liedtke et al. | Cyclooxygenase-1-selective inhibitors based on the (E)-2′-des-methyl-sulindac sulfide scaffold | |
| Han et al. | Semisynthetic derivatives of sesquiterpene lactones by palladium-catalyzed arylation of the α-methylene-γ-lactone substructure | |
| Fotie et al. | Antitrypanosomal activity of 1, 2-dihydroquinolin-6-ols and their ester derivatives | |
| Black et al. | 2, 3-Diarylcyclopentenones as orally active, highly selective cyclooxygenase-2 inhibitors | |
| Küçükgüzel et al. | Synthesis of tolmetin hydrazide–hydrazones and discovery of a potent apoptosis inducer in colon cancer cells | |
| Morgan et al. | Design, synthesis, and anticancer properties of 4, 4 ‘-dihydroxybenzophenone-2, 4-dinitrophenylhydrazone and analogues | |
| Chiroli et al. | Nitric oxide-donating non-steroidal anti-inflammatory drugs: the case of nitroderivatives of aspirin | |
| Peduto et al. | Optimization of benzoquinone and hydroquinone derivatives as potent inhibitors of human 5-lipoxygenase | |
| Ohno et al. | Development of dual-acting benzofurans for thromboxane A2 receptor antagonist and prostacyclin receptor agonist: synthesis, structure− activity relationship, and evaluation of benzofuran derivatives | |
| Mukherjee et al. | Catalyst-free one-pot three-component synthesis of 4-hydroxy-3-pyrazolylcoumarins in ethanol at room temperature: enolisable aroylhydrazones as efficient ambident nucleophile | |
| Bruno et al. | Structural insight into the optimization of ethyl 5-hydroxybenzo [g] indol-3-carboxylates and their bioisosteric analogues as 5-LO/m-PGES-1 dual inhibitors able to suppress inflammation | |
| Wang et al. | Design, synthesis, and biological evaluation of shikonin and alkannin derivatives as potential anticancer agents via a prodrug approach | |
| Qin et al. | A Mild and Direct C (sp3)–S Cross-Coupling of Oxindoles with Thiols: Synthesis of Unsymmetrical 3-Thiooxindoles | |
| Shen et al. | Design, synthesis, and structure activity relationships for chimeric inhibitors of Hsp90 | |
| Deny et al. | Bis-Michael acceptors as novel probes to study the Keap1/Nrf2/ARE pathway | |
| Svouraki et al. | Evaluation of dual 5-lipoxygenase/microsomal prostaglandin E2 synthase-1 inhibitory effect of natural and synthetic acronychia-type isoprenylated acetophenones | |
| Sun et al. | Design, synthesis, and bioactivity of chalcone derivatives containing indanone | |
| Duca et al. | Synthesis and biological study of a new series of 4 ‘-demethylepipodophyllotoxin derivatives |